Your browser doesn't support javascript.
loading
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Zhou, Quan; Zhang, Hongyu; Wang, Zewei; Zeng, Han; Liu, Zhaopei; Huang, Qiuren; Lin, Zhiyuan; Qu, Yang; Xiong, Ying; Wang, Jiajun; Chang, Yuan; Bai, Qi; Xia, Yu; Wang, Yiwei; Liu, Li; Dai, Bo; Guo, Jianming; Zhu, Yu; Xu, Le; Xu, Jiejie.
Afiliação
  • Zhou Q; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Zhang H; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Wang Z; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zeng H; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Liu Z; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Huang Q; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Lin Z; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qu Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xiong Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chang Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Bai Q; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xia Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang Y; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Liu L; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Dai B; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu L; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu J; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Int J Cancer ; 147(12): 3539-3549, 2020 12 15.
Article em En | MEDLINE | ID: mdl-32734613

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article